Posted on 30 May 2018
Paul Zagar wrote an article titled “Praxair and the Printed Matter Doctrine,” which was published in IP, Life Sciences, and Appellate Law360 on May 18, 2018 and as an expert analysis in Law 360’s newsletters on May 21, 2018. The article made Law360’s “10 Most Read Expert Analysis” articles for that week. See https://www.law360.com/articles/1045196/praxair-and-the-printed-matter-doctrine. The article summarizes and comments on a recent Federal Circuit decision that affirmed in part a Patent Trial and Appeal Board (PTAB) decision invalidating method of treatment claims including a “providing information” limitation by applying the printed matter doctrine.